Neuroimaging, nutrition, and iron-related genes

Cellular and Molecular Life Sciences

Volumn 70, Issue 23, 2013, Pages 4449-4461

  Jahanshad, Neda ^a   Rajagopalan, Priya ^a   Thompson, Paul M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain development; Diet; Genetics; HFE; Iron; Neuroimaging; Nutrition; Transferrin

Indexed keywords

CHOLINE; CYANOCOBALAMIN; FOLIC ACID; IRON; OMEGA 3 FATTY ACID; PYRIDOXINE; TRANSFERRIN; VITAMIN B GROUP; VITAMIN D;

ACO1 GENE; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN LEVEL; COGNITION; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; FEEDING BEHAVIOR; FUNCTIONAL ANATOMY; GENE; GENE FUNCTION; GENETIC VARIABILITY; GENETICS; HEPH GENE; HFE GENE; HFE2 GENE; HUMAN; IRON TRANSPORT; MENTAL HEALTH; NEO1 GENE; NERVE CELL NETWORK; NEUROANATOMY; NEUROIMAGING; NEUROPATHOLOGY; NUTRITION; NUTRITIONAL HEALTH; REVIEW; TF GENE; TFR2 GENE; TFRC GENE; VITAMIN SUPPLEMENTATION;

BRAIN; DIETARY SUPPLEMENTS; HUMANS; IRON; IRON REGULATORY PROTEIN 1; NEUROIMAGING; NUTRIGENOMICS; NUTRITIONAL STATUS; RECEPTORS, TRANSFERRIN; TRANSFERRIN;

EID: 84889879929     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1369-2     Document Type: Review

References (123)

1. Georgieff MK (2007) Nutrition and the developing brain: nutrient priorities and measurement. Am J Clin Nutr 85:614S-620S
2. Beard JL, Connor JR, Jones BC (1993) Iron in the brain. Nutr Rev 51:157-170
3. Thompson PM, Jahanshad N (2012) Ironing out neurodegeneration: is iron intake important during the teenage years? Expert Rev Neurother 12:629-631
4. Thompson PM, Martin NG, Wright MJ (2010) Imaging genomics. Curr Opin Neurol 23:368-373
5. Braskie MN, Ringman JM, Thompson PM (2011) Neuroimaging measures as endophenotypes in Alzheimer's disease. Int J Alzheimers Dis 2011:490140
6. Honea RA, Vidoni E, Harsha A, Burns JM (2009) Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. J Alzheimers Dis 18:553-564
7. Braskie MN, Jahanshad N, Stein JL, Barysheva M, McMahon KL, de Zubicaray GI, Martin NG, Wright MJ, Ringman JM, Toga AW et al (2011) Common Alzheimer's disease risk variant within the CLU gene affects white matter microstructure in young adults. J Neurosci 31:6764-6770
8. Rajagopalan P, Jahanshad N, Stein JL, Kohannim O, Hibar DP, Hua X, Toga AW, J CR Jr, Saykin AJ, Green RC et al (2012) Commonly carried C677T risk variant in the folate pathway candidate gene, MTHFR, promotes brain deficits in the cognitively impaired elderly. NeuroImage-Clin 1:179-187
9. Sprooten E, Sussmann JE, Moorhead TW, Whalley HC, Ffrench-Constant C, Blumberg HP, Bastin ME, Hall J, Lawrie SM, McIntosh AM (2011) Association of white matter integrity with genetic variation in an exonic DISC1 SNP. Mol Psychiatry 16(685):688-689
10. McIntosh AM, Moorhead TW, Job D, Lymer GK, Munoz Maniega S, McKirdy J, Sussmann JE, Baig BJ, Bastin ME, Porteous D et al (2008) The effects of a neuregulin 1 variant on white matter density and integrity. Mol Psychiatry 13:1054-1059
11. Braskie MN, Jahanshad N, Stein JL, Barysheva M, Johnson K, McMahon KL, de Zubicaray GI, Martin NG, Wright MJ, Ringman JM et al (2012) Relationship of a variant in the NTRK1 gene to white matter microstructure in young adults. J Neurosci 32:5964-5972
12. Dennis EL, Jahanshad N, Rudie JD, Brown JA, Johnson K, McMahon KL, de Zubicaray GI, Montgomery G, Martin NG, Wright MJ et al (2011) Altered structural brain connectivity in healthy carriers of the autism risk gene, CNTNAP2. Brain Connect 1:447-459
13. Rudie JD, Hernandez LM, Brown JA, Beck-Pancer D, Colich NL, Gorrindo P, Thompson PM, Geschwind DH, Bookheimer SY, Levitt P et al (2012) Autism-associated promoter variant in MET impacts functional and structural brain networks. Neuron 75:904-915
14. Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, Toro R, Appel K, Bartecek R, Bergmann O et al (2012) Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet 44:552-561
15. Taal HR, St Pourcain B, Thiering E, Das S, Mook-Kanamori DO, Warrington NM, Kaakinen M, Kreiner-Moller E, Bradfield JP, Freathy RM et al (2012) Common variants at 12q15 and 12q24 are associated with infant head circumference. Nat Genet 44:532-538
16. Ikram MA, Fornage M, Smith AV, Seshadri S, Schmidt R, Debette S, Vrooman HA, Sigurdsson S, Ropele S, Taal HR et al (2012) Common variants at 6q22 and 17q21 are associated with intracranial volume. Nat Genet 44:539-544
17. Bis JC, DeCarli C, Smith AV, van der Lijn F, Crivello F, Fornage M, Debette S, Shulman JM, Schmidt H, Srikanth V et al (2012) Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet 44:545-551
18. Jahanshad N, Kohannim O, Hibar DP, Stein JL, McMahon KL, de Zubicaray GI, Medland SE, Montgomery GW, Whitfield JB, Martin NG et al (2012) Brain structure in healthy adults is related to serum transferrin and the H63D polymorphism in the HFE gene. Proc Natl Acad Sci USA 109:E851-E859
19. Thompson PM, Hayashi KM, Sowell ER, Gogtay N, Giedd JN, Rapoport JL, de Zubicaray GI, Janke AL, Rose SE, Semple J et al (2004) Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage 23(Suppl 1):S2-S18
20. Luders E, Narr KL, Thompson PM, Rex DE, Jancke L, Steinmetz H, Toga AW (2004) Gender differences in cortical complexity. Nat Neurosci 7:799-800
21. Hua X, Hibar DP, Ching CR, Boyle CP, Rajagopalan P, Gutman BA, Leow AD, Toga AW, Jack CR Jr, Harvey D et al (2013) Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials. Neuroimage 66C:648-661
22. Jahanshad N, Kochunov P, Sprooten E, Mandl RC, Nichols TE, Almasy L, Blangero J, Brouwer RM, Curran JE, de Zubicaray GI et al. (2013) Multi-site genetic analysis of diffusion images and voxelwise heritability analysis: A pilot project of the ENIGMA-DTI working group. Neuroimage, In Press
23. Prasad G, Joshi SH, Jahanshad N, Villalon J, Aganj I, Lenglet C, Sapiro G, McMahon KL, de Zubicaray GI, Martin NG (2011) White matter tract analysis in 454 adults using maximum density paths, Proc. MICCAI 2011 Workshop on computational diffusion MRI, September 18-22, 2011
24. Jahanshad N, Valcour VG, Nir TM, Kohannim O, Busovaca E, Nicolas K, Thompson PM (2012) Disrupted brain networks in the aging HIV + population. Brain Connect 2:335-344
25. Engel J, Thompson P, Stern J, Staba R, Bragin A, Mody I (2013) Connectomics and epilepsy. Curr Opin Neurol 26:186-194
26. Jahanshad N, Rajagopalan P, Hua X, Hibar DP, Nir TM, Toga AW, Jack CR, Saykin AJ, Green RC, Weiner MW et al (2013) Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity. Proc Natl Acad Sci USA 110:4768-4773
27. Nir T, Jahanshad N, Busovaca E, Wendelken L, Nicolas K, Thompson P, Valcour V (2012) Mapping white matter integrity in elderly people with HIV. Human Brain Mapp. In Press
28. Bourre JM (2006) Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J Nutr Health Aging 10:386-399
29. Bourre JM (2006) Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging 10:377-385
30. den Hollander B, Schouw M, Groot P, Huisman H, Caan M, Barkhof F, Reneman L (2012) Preliminary evidence of hippocampal damage in chronic users of ecstasy. J Neurol Neurosurg Psychiatry 83:83-85
31. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED (2004) Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 24:6028-6036
32. Sowell ER, Leow AD, Bookheimer SY, Smith LM, O'Connor MJ, Kan E, Rosso C, Houston S, Dinov ID, Thompson PM (2010) Differentiating prenatal exposure to methamphetamine and alcohol versus alcohol and not methamphetamine using tensor-based brain morphometry and discriminant analysis. J Neurosci 30:3876-3885
33. Pfefferbaum A, Adalsteinsson E, Sullivan EV (2006) Dysmorphology and microstructural degradation of the corpus callosum: interaction of age and alcoholism. Neurobio Aging 27:994-1009
34. Isaacs EB, Gadian DG, Sabatini S, Chong WK, Quinn BT, Fischl BR, Lucas A (2008) The effect of early human diet on caudate volumes and IQ. Pediatr Res 63:308-314
35. Ho AJ, Raji CA, Becker JT, Lopez OL, Kuller LH, Hua X, Dinov ID, Stein JL, Rosano C, Toga AW et al (2011) The effects of physical activity, education, and body mass index on the aging brain. Hum Brain Mapp 32:1371-1382
36. Davey Smith G, Ebrahim S (2003) Mendelian randomization: can genetic epidemiology contribute to understanding environmental determinants of disease? Intern J Epidemiol 32:1-22
37. Virtanen JK, Siscovick DS, Longstreth WT Jr, Kuller LH, Mozaffarian D (2008) Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology 71:439-446
38. Boyle C, Raji CA, Teverovskiy L, Rajagopalan P, Madsen SK, Kuller L, Carmichael OT, Becker JT, Lopez OL, Thompson PM (2012) In organization for human brain mapping (OHBM). Beijing, China
39. Tan ZS, Harris WS, Beiser AS, Au R, Himali JJ, Debette S, Pikula A, Decarli C, Wolf PA, Vasan RS et al (2012) Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology 78:658-664
40. Ching C, Rajagopalan P, Toga AW, J CR Jr, Weiner MW, Thompson PM (2012) In Proc. society for neuroscience. New Orleans, LA
41. Erickson KI, Suever BL, Prakash RS, Colcombe SJ, McAuley E, Kramer AF (2008) Greater intake of vitamins B6 and B12 spares gray matter in healthy elderly: a voxel-based morphometry study. Brain Res 1199:20-26
42. de Lau LM, Smith AD, Refsum H, Johnston C, Breteler MM (2009) Plasma vitamin B12 status and cerebral white-matter lesions. J Neurol Neurosurg Psychiatry 80:149-157
43. Poly C, Massaro JM, Seshadri S, Wolf PA, Cho E, Krall E, Jacques PF, Au R (2011) The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham offspring cohort. Am J of Clin Nutr 94:1584-1591
44. Rajagopalan P, Hua X, Toga AW, Jack CR Jr, Weiner MW, Thompson PM (2011) Homocysteine effects on brain volumes mapped in 732 elderly individuals. NeuroReport 22:391-395
45. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New Engl J Med 346:476-483
46. Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26:137-146
47. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM (1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55:1449-1455
48. Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H (2010) Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One 5:e12244
49. Conklin SM, Gianaros PJ, Brown SM, Yao JK, Hariri AR, Manuck SB, Muldoon MF (2007) Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci Letters 421:209-212
50. Samieri C, Maillard P, Crivello F, Proust-Lima C, Peuchant E, Helmer C, Amieva H, Allard M, Dartigues JF, Cunnane SC et al (2012) Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe. Neurology 79:642-650
51. Payne ME, Anderson JJ, Steffens DC (2008) Calcium and vitamin D intakes may be positively associated with brain lesions in depressed and nondepressed elders. Nutr Res 28:285-292
52. Weinstock-Guttman B, Zivadinov R, Qu J, Cookfair D, Duan X, Bang E, Bergsland N, Hussein S, Cherneva M, Willis L et al (2011) Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients. J Neurol Neurosurg Psychiatry 82:189-195
53. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, Qui WQ, Bergethon P, Rosenberg IH, Folstein MF, Patz S et al (2010) 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 74:18-26
54. Peran P, Cherubini A, Luccichenti G, Hagberg G, Demonet JF, Rascol O, Celsis P, Caltagirone C, Spalletta G, Sabatini U (2009) Volume and iron content in basal ganglia and thalamus. Hum Brain Mapp 30:2667-2675
55. Cortese S, Azoulay R, Castellanos FX, Chalard F, Lecendreux M, Chechin D, Delorme R, Sebag G, Sbarbati A, Mouren MC et al (2012) Brain iron levels in attention-deficit/hyperactivity disorder: a pilot MRI study. World J Biol Psychiatry 13:223-231
56. Bartzokis G, Sultzer D, Cummings J, Holt LE, Hance DB, Henderson VW, Mintz J (2000) In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Arch Gen Psychiatry 57:47-53
57. Wang Y, Butros SR, Shuai X, Dai Y, Chen C, Liu M, Haacke EM, Hu J, Xu H (2012) Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging. Am J Neurorad 33:266-273
58. House MJ, St Pierre TG, Milward EA, Bruce DG, Olynyk JK (2010) Relationship between brain R(2) and liver and serum iron concentrations in elderly men. Mag Reson Med 63:275-281
59. 2002 Iron deficiency - United States, 1999-2000. MMWR. Morbidity and mortality weekly report, 51, 897-899
60. Lozoff B, Beard J, Connor J, Barbara F, Georgieff M, Schallert T (2006) Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutrition Rev 64:S34-s43 (Discussion S72-91)
61. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5:863-873
62. Haacke EM, Reichenbach JR (2011) Susceptibility weighted imaging in MRI: basic concepts and clinical applications. Wiley-Blackwell, Hoboken
63. Fischer A, Hall L (1994) Roles for paramagnetic substances in MRI: contrast agents, molecular amplifiers, and indicators for redox and pH mapping. Mag Res Mater Physics Biol Med 2:203-210
64. Desai V, Kaler SG (2008) Role of copper in human neurological disorders. Am J Clin Nutrition 88:855S-858S
65. Frederickson CJ, Koh JY, Bush AI (2005) The neurobiology of zinc in health and disease. Nat Rev Neurosci 6:449-462
66. Moos T, Rosengren Nielsen T, Skjorringe T, Morgan EH (2007) Iron trafficking inside the brain. J Neurochem 103:1730-1740
67. Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR (2009) Oligodendrocytes and myelination: the role of iron. Glia 57:467-478
68. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5:863-873
69. Halterman JS, Kaczorowski JM, Aligne CA, Auinger P, Szilagyi PG (2001) Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics 107:1381-1386
70. Stoltzfus RJ, Kvalsvig JD, Chwaya HM, Montresor A, Albonico M, Tielsch JM, Savioli L, Pollitt E (2001) Effects of iron supplementation and anthelmintic treatment on motor and language development of preschool children in Zanzibar: double blind, placebo controlled study. BMJ 323:1389-1393
71. Solomon I (1955) Relaxation processes in a system of two spins. Phys Rev 99:559-565
72. Prince JL, Links JM (2006) Medical imaging signals and systems. Pearson Prentice Hall, Upper Saddle River
73. Bartzokis G, Sultzer D, Mintz J, Holt LE, Marx P, Phelan CK, Marder SR (1994) In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI. Biol Psychiatry 35:480-487
74. Bartzokis G, Cummings JL, Markham CH, Marmarelis PZ, Treciokas LJ, Tishler TA, Marder SR, Mintz J (1999) MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imag 17:213-222
75. Jurgens, C.K., Jasinschi, R., Ekin, A., Witjes-Ane, M.N., Middelkoop, H., van der Grond, J. and Roos, R. (2010) MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease. PLoS Curr. 2
76. Ke Y, Ming Qian Z (2003) Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2:246-253
77. Benarroch EE (2009) Brain iron homeostasis and neurodegenerative disease. Neurology 72:1436-1440
78. Moos T, Morgan EH (2000) Transferrin and transferrin receptor function in brain barrier systems. Cell Mol Neurobiol 20:77-95
79. Das Gupta A, Abbi A (2003) High serum transferrin receptor level in anemia of chronic disorders indicates coexistent iron deficiency. Am J Hematol 72:158-161
80. Khumalo H, Gomo ZA, Moyo VM, Gordeuk VR, Saungweme T, Rouault TA, Gangaidzo IT (1998) Serum transferrin receptors are decreased in the presence of iron overload. Clin Chem 44:40-44
81. Suominen P, Virtanen A, Lehtonen-Veromaa M, Heinonen OJ, Salmi TT, Alanen M, Mottonen T, Rajamaki A, Irjala K (2001) Regression-based reference limits for serum transferrin receptor in children 6 months to 16 years of age. Clin Chem 47:935-937
82. Lynch SR, Cook JD (1980) Interaction of vitamin C and iron. Ann NY Acad Sci 355:32-44
83. Whitfield JB, Cullen LM, Jazwinska EC, Powell LW, Heath AC, Zhu G, Duffy DL, Martin NG (2000) Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet 66:1246-1258
84. Baynes RD (1996) Assessment of iron status. Clin Biochem 29:209-215
85. Ahluwalia N (1998) Diagnostic utility of serum transferrin receptors measurement in assessing iron status. Nutr Rev 56:133-141
86. Drayer B, Burger P, Darwin R, Riederer S, Herfkens R, Johnson GA (1986) MRI of brain iron. Am J Roentgenol 147:103-110
87. Constantine CC, Gurrin LC, McLaren CE, Bahlo M, Anderson GJ, Vulpe CD, Forrest SM, Allen KJ, Gertig DM (2008) SNP selection for genes of iron metabolism in a study of genetic modifiers of hemochromatosis. BMC Med Genet 9:18
88. McLaren CE, McLachlan S, Garner CP, Vulpe CD, Gordeuk VR, Eckfeldt JH, Adams PC, Acton RT, Murray JA, Leiendecker-Foster C et al (2012) Associations between single-nucleotide polymorphisms in iron-related genes and iron status in multiethnic populations. PLoS One 7:e38339
89. Hanninen MM, Haapasalo J, Haapasalo H, Fleming RE, Britton RS, Bacon BR, Parkkila S (2009) Expression of iron-related genes in human brain and brain tumors. BMC Neurosci 10:36
90. Spiegel R, Pines O, Ta-Shma A, Burak E, Shaag A, Halvardson J, Edvardson S, Mahajna M, Zenvirt S, Saada A et al (2012) Infantile cerebellar-retinal degeneration associated with a mutation in mitochondrial aconitase, ACO2. Am J Hum Genet 90:518-523
91. Lin M, Zhao L, Fan J, Lian XG, Ye JX, Wu L, Lin H (2012) Association between HFE polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis of 22 studies including 4,365 cases and 8,652 controls. Mol Biol Rep 39:3089-3095
92. Blazquez L, De Juan D, Ruiz-Martinez J, Emparanza JI, Saenz A, Otaegui D, Sistiaga A, Martinez-Lage P, Lamet I, Samaranch L et al (2007) Genes related to iron metabolism and susceptibility to Alzheimer's disease in Basque population. Neurobio Aging 28:1941-1943
93. Guerreiro RJ, Bras JM, Santana I, Januario C, Santiago B, Morgadinho AS, Ribeiro MH, Hardy J, Singleton A, Oliveira C (2006) Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort. BMC Neurol 6:24
94. Candore G, Licastro F, Chiappelli M, Franceschi C, Lio D, Rita Balistreri C, Piazza G, Colonna-Romano G, Grimaldi LM, Caruso C (2003) Association between the HFE mutations and unsuccessful ageing: a study in Alzheimer's disease patients from northern Italy. Mech Ageing Dev 124:525-528
95. Sutedja NA, Sinke RJ, Van Vught PW, Van der Linden MW, Wokke JH, Van Duijn CM, Njajou OT, Van der Schouw YT, Veldink JH, Van den Berg LH (2007) The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population. Arch Neurol 64:63-67
96. He X, Lu X, Hu J, Xi J, Zhou D, Shang H, Liu L, Zhou H, Yan B, Yu L et al (2011) H63D polymorphism in the hemochromatosis gene is associated with sporadic amyotrophic lateral sclerosis in China. Euro J Neurol 18:359-361
97. Praline J, Blasco H, Vourc'h P, Rat V, Gendrot C, Camu W, Andres CR (2012) Study of the HFE gene common polymorphisms in French patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci 317:58-61
98. van Rheenen, W., Diekstra, F.P., van Doormaal, P.T., Seelen, M., Kenna, K., McLaughlin, R., Shatunov, A., Czell, D., van Es, M.A., van Vught, P.W. et al. (2012) H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis. Neurobio Aging. In Press
99. Gemmati D, Zeri G, Orioli E, De Gaetano FE, Salvi F, Bartolomei I, D'Alfonso S, Dall'osso C, Leone MA, Singh AV et al (2012) Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis. BMC Med Genet 13:70
100. Borie C, Gasparini F, Verpillat P, Bonnet AM, Agid Y, Hetet G, Brice A, Durr A, Grandchamp B (2002) Association study between iron-related genes polymorphisms and Parkinson's disease. J Neurol 249:801-804
101. Oexle K, Schormair B, Ried JS, Czamara D, Heim K, Frauscher B, Hogl B, Trenkwalder C, Martin Fiedler G, Thiery J et al (2012) Dilution of candidates: the case of iron-related genes in restless legs syndrome. Eur J Hum Genet 21:410-414
102. Rosenfeld JA, Ballif BC, Torchia BS, Sahoo T, Ravnan JB, Schultz R, Lamb A, Bejjani BA, Shaffer LG (2010) Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders. Genet Med 12:694-702
103. Gebril OH, Meguid NA (2011) HFE gene polymorphisms and the risk for autism in Egyptian children and impact on the effect of oxidative stress. Dis Markers 31:289-294
104. Bartzokis G, Lu PH, Tishler TA, Peters DG, Kosenko A, Barrall KA, Finn JP, Villablanca P, Laub G, Altshuler LL et al (2010) Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men. J Alzheimers Dis 20:333-341
105. Bartzokis G, Lu PH, Tingus K, Peters DG, Amar CP, Tishler TA, Finn JP, Villablanca P, Altshuler LL, Mintz J et al (2011) Gender and iron genes may modify associations between brain iron and memory in healthy aging. Neuropsychopharmacology 36:1375-1384
106. Kauwe JS, Bertelsen S, Mayo K, Cruchaga C, Abraham R, Hollingworth P, Harold D, Owen MJ, Williams J, Lovestone S et al (2010) Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease. Am J Med Genet B Neuropsychiatr genet 153B:955-959
107. Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, Coulthard A, Jackson MJ, Jackson AP, McHale DP et al (2001) Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28:350-354
108. Zhang P, Yang Z, Zhang C, Lu Z, Shi X, Zheng W, Wan C, Zhang D, Zheng C, Li S et al (2003) Association study between late-onset Alzheimer's disease and the transferrin gene polymorphisms in Chinese. Neurosci Lett 349:209-211
109. Schjeide BM, McQueen MB, Mullin K, DiVito J, Hogan MF, Parkinson M, Hooli B, Lange C, Blacker D, Tanzi RE et al (2009) Assessment of Alzheimer's disease case-control associations using family-based methods. Neurogenetics 10:19-25
110. Laumet G, Chouraki V, Grenier-Boley B, Legry V, Heath S, Zelenika D, Fievet N, Hannequin D, Delepine M, Pasquier F et al (2010) Systematic analysis of candidate genes for Alzheimer's disease in a French, genome-wide association study. J Alzheimers Dis 20:1181-1188
111. Van Landeghem GF, Sikstrom C, Beckman LE, Adolfsson R, Beckman L (1998) Transferrin C2, metal binding and Alzheimer's disease. NeuroReport 9:177-179
112. Ezquerra M, Campdelacreu J, Munoz E, Tolosa E (2005) Association study of the G258S transferrin gene polymorphism and Parkinson's disease in the Spanish population. J Neurology 252:1269-1270
113. Qu M, Yue W, Tang F, Wang L, Han Y, Zhang D (2008) Polymorphisms of Transferrin gene are associated with schizophrenia in Chinese Han population. J Psychiatric Res 42:877-883
114. Maeno N, Takahashi N, Saito S, Ji X, Branko A, Ishihara R, Yoshida K, Inada T, Iidaka T, Ozaki N (2007) Association study between the transferrin gene and schizophrenia in the Japanese population. NeuroReport 18:517-520
115. Santos PC, Dinardo CL, Cancado RD, Schettert IT, Krieger JE, Pereira AC (2012) Non-HFE hemochromatosis. Rev Bras Hematol Hemoter 34:311-316
116. Pietrangelo A, Caleffi A, Corradini E (2011) Non-HFE hepatic iron overload. Semin Liver Dis 31:302-318
117. Synowiec E, Pogorzelska M, Blasiak J, Szaflik J, Szaflik JP (2012) Genetic polymorphism of the iron-regulatory protein-1 and -2 genes in age-related macular degeneration. Mol Biol Rep 39:7077-7087
118. Yang F, West AP Jr, Bjorkman PJ (2011) Crystal structure of a hemojuvelin-binding fragment of neogenin at 1.8A. J Struct Biol 174:239-244
119. Lin L, Goldberg YP, Ganz T (2005) Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 106:2884-2889
120. Herbison CE, Thorstensen K, Chua AC, Graham RM, Leedman P, Olynyk JK, Trinder D (2009) The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells. Am J Physiol Cell Physiol 297:C1567-C1575
121. Chen H, Su T, Attieh ZK, Fox TC, McKie AT, Anderson GJ, Vulpe CD (2003) Systemic regulation of Hephaestin and Ireg1 revealed in studies of genetic and nutritional iron deficiency. Blood 102:1893-1899
122. Benyamin B, McRae AF, Zhu G, Gordon S, Henders AK, Palotie A, Peltonen L, Martin NG, Montgomery GW, Whitfield JB et al (2009) Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. Am J Hum Genet 84:60-65
123. Nandar W, Connor JR (2011) HFE gene variants affect iron in the brain. J Nutr 141:729S-739S